Skip to main content

Table 3 Independent factors associated with the recurrence of HCC after DAA treatment in the overall period according to Cox proportional hazard model analysis

From: AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy

 

Hazard ratio

95% CI

p-value

Male

1.75

1.09–2.80

0.019

No SVR

2.30

1.17–4.52

0.015

Number of curative treatments for HCC

1.21

1.07–1.36

0.001

  1. Data are expressed as means ± standard deviation
  2. ALT alanine aminotransferase; AST aspartate aminotransferase; AFP α-fetoprotein; eGFR estimated glomerular filtration rate; FIB-4 fibrosis-4; APRI AST to platelet ratio index; SVR sustained viral response; BCLC Barcelona Clinic Liver Cancer; CI confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us